div class=”ChapterContextInformation”> © Springer Nature Switzerland AG 2020O. FreudenreichPsychotic DisordersCurrent Clinical Psychiatryhttps://doi.org/10.1007/978-3-030-29450-2_21 21. Polypharmacy Oliver Freudenreich1 (1) Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA KeywordsPolypharmacyRational prescribingDeprescribingPreventionHippocratic medicineBeer Criteria® Essential Concepts Polypharmacy…
div class=”ChapterContextInformation”> © Springer Nature Switzerland AG 2020O. FreudenreichPsychotic DisordersCurrent Clinical Psychiatryhttps://doi.org/10.1007/978-3-030-29450-2_19 19. Adjunctive Medications Oliver Freudenreich1 (1) Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA KeywordsAdd-on strategiesNonpsychotic symptom clustersDepressionAntidepressantsAnxiolyticsBenzodiazepine indicationsInsomniaSedative-hypnoticsAntiepileptic drugsLithiumValproateCarbamazepineOxcarbazepineTopiramateAnticholinergicsHerbal…
div class=”ChapterContextInformation”> © Springer Nature Switzerland AG 2020O. FreudenreichPsychotic DisordersCurrent Clinical Psychiatryhttps://doi.org/10.1007/978-3-030-29450-2_18 18. Long-Acting Injectable Antipsychotics Oliver Freudenreich1 (1) Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA KeywordsLong-acting injectable antipsychoticsLAIsRelapse preventionBenefitsIndicationsHarm reductionPatient…
div class=”ChapterContextInformation”> © Springer Nature Switzerland AG 2020O. FreudenreichPsychotic DisordersCurrent Clinical Psychiatryhttps://doi.org/10.1007/978-3-030-29450-2_11 11. First-Episode Psychosis Oliver Freudenreich1 (1) Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA KeywordsDiagnosisProdromeUltrahigh riskTransition to psychosisCourse of first-episode…
div class=”ChapterContextInformation”> © Springer Nature Switzerland AG 2020O. FreudenreichPsychotic DisordersCurrent Clinical Psychiatryhttps://doi.org/10.1007/978-3-030-29450-2_5 5. Secondary Schizophrenia Oliver Freudenreich1 (1) Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA KeywordsDifferential diagnosisPrimary psychosisSecondary psychosisClinical presentationDiagnosisMedical work-upSecondary…
div class=”ChapterContextInformation”> © Springer Nature Switzerland AG 2020O. FreudenreichPsychotic DisordersCurrent Clinical Psychiatryhttps://doi.org/10.1007/978-3-030-29450-2_9 9. Prevention and Clinical Staging Oliver Freudenreich1 (1) Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA KeywordsPreventionPsychosocial toxicityPrimary preventionSecondary preventionEarly…
div class=”ChapterContextInformation”> © Springer Nature Switzerland AG 2020O. FreudenreichPsychotic DisordersCurrent Clinical Psychiatryhttps://doi.org/10.1007/978-3-030-29450-2_7 7. Natural History of Schizophrenia Oliver Freudenreich1 (1) Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA KeywordsNatural historyCourseOnsetChildhood-onset schizophrenia (COS)Late-onset…
div class=”ChapterContextInformation”> © Springer Nature Switzerland AG 2020O. FreudenreichPsychotic DisordersCurrent Clinical Psychiatryhttps://doi.org/10.1007/978-3-030-29450-2_16 16. Antipsychotics: Clinical Effectiveness Oliver Freudenreich1 (1) Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA KeywordsLarge pragmatic trialsCATIEEvidence-based psychiatryClinical guidelinesSymptomatic…
div class=”ChapterContextInformation”> © Springer Nature Switzerland AG 2020O. FreudenreichPsychotic DisordersCurrent Clinical Psychiatryhttps://doi.org/10.1007/978-3-030-29450-2_1 1. Psychotic Signs and Symptoms Oliver Freudenreich1 (1) Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA KeywordsPsychosisDescriptive psychopathologyDelusionsOvervalued ideasHallucinationsPseudohallucinationsEponymsSchneiderian first-rank…
div class=”ChapterContextInformation”> © Springer Nature Switzerland AG 2020O. FreudenreichPsychotic DisordersCurrent Clinical Psychiatryhttps://doi.org/10.1007/978-3-030-29450-2_12 12. Treatment-Resistant Schizophrenia Oliver Freudenreich1 (1) Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA KeywordsTreatment-resistant schizophreniaPseudo-refractorinessTherapeutic drug monitoringLong-acting injectable antipsychotic…
